These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

159 related articles for article (PubMed ID: 16046128)

  • 41. Hapten design for the generation of catalytic antibodies.
    Thomas NR
    Appl Biochem Biotechnol; 1994; 47(2-3):345-72. PubMed ID: 7944348
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Polyclonal antibody catalytic variability.
    Stephens DB; Thomas RE; Stanton JF; Iverson BL
    Biochem J; 1998 May; 332 ( Pt 1)(Pt 1):127-34. PubMed ID: 9576860
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Folate-targeted dinitrophenyl hapten immunotherapy: effect of linker chemistry on antitumor activity and allergic potential.
    Lu Y; You F; Vlahov I; Westrick E; Fan M; Low PS; Leamon CP
    Mol Pharm; 2007; 4(5):695-706. PubMed ID: 17784727
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Preparation of a multi-hapten antigen and broad specificity polyclonal antibodies for a multiple pesticide immunoassay.
    Wang ST; Gui WJ; Guo YR; Zhu GN
    Anal Chim Acta; 2007 Mar; 587(2):287-92. PubMed ID: 17386785
    [TBL] [Abstract][Full Text] [Related]  

  • 45. The scope of antibody catalysis.
    Jacobsen JR; Schultz PG
    Curr Opin Struct Biol; 1995 Dec; 5(6):818-24. PubMed ID: 8749371
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Dependence of properties of polyclonal antibodies to (2'-5')-oligoadenylates on the method of hapten binding to an immunogen].
    Kulak TI; Kvasiuk EI; Sentiureva SL; Shuliakovskaia SM; Matiushevskaia VP; Makarenko MV; Mikhaĭlopulo IA
    Bioorg Khim; 1999 Sep; 25(9):679-89. PubMed ID: 10624560
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Peptide synthesis catalyzed by an antibody containing a binding site for variable amino acids.
    Hirschmann R; Smith AB; Taylor CM; Benkovic PA; Taylor SD; Yager KM; Sprengeler PA; Benkovic SJ
    Science; 1994 Jul; 265(5169):234-7. PubMed ID: 8023141
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immune recognition, antigen design, and catalytic antibody production.
    Tramontano A
    Appl Biochem Biotechnol; 1994; 47(2-3):257-73; discussion 273-5. PubMed ID: 7944342
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Hapten Design and Monoclonal Antibody to Fluoroacetamide, a Small and Highly Toxic Chemical.
    Yang L; Zhang X; Shen D; Yu X; Li Y; Wen K; Shen J; Wang Z
    Biomolecules; 2020 Jul; 10(7):. PubMed ID: 32630260
    [TBL] [Abstract][Full Text] [Related]  

  • 50. [Antitoxic response of paraoxon-hemocyanin immunized rabbits (author's transl)].
    Rong KT
    Zhonghua Yu Fang Yi Xue Za Zhi; 1980 Aug; 14(3):133-6. PubMed ID: 7472050
    [No Abstract]   [Full Text] [Related]  

  • 51. Production and characterization of a broad-specificity polyclonal antibody for O,O-diethyl organophosphorus pesticides and a quantitative structure-activity relationship study of antibody recognition.
    Xu ZL; Xie GM; Li YX; Wang BF; Beier RC; Lei HT; Wang H; Shen YD; Sun YM
    Anal Chim Acta; 2009 Aug; 647(1):90-6. PubMed ID: 19576391
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Reductively aminated D-xylose-albumin conjugate as the immunogen for generation of IgG and IgE antibodies specific to D-xylitol, a haptenic allergen.
    Sreenath K; Venkatesh YP
    Bioconjug Chem; 2007; 18(6):1995-2003. PubMed ID: 17979222
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Development of murine monoclonal antibodies to methamphetamine and methamphetamine analogues.
    Danger Y; Gadjou C; Devys A; Galons H; Blanchard D; Folléa G
    J Immunol Methods; 2006 Feb; 309(1-2):1-10. PubMed ID: 16412457
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Design and syntheses of three haptens to generate catalytic antibodies that cleave amide bonds with nucleophilic catalysis.
    Ersoy O; Fleck R; Blanco MJ; Masamune S
    Bioorg Med Chem; 1999 Feb; 7(2):279-86. PubMed ID: 10218819
    [TBL] [Abstract][Full Text] [Related]  

  • 55. An improved rapid method for selecting monoclonal antibodies with high catalytic activities.
    Yuan YR; Yang BH; Ji YY
    J Protein Chem; 1997 Nov; 16(8):733-8. PubMed ID: 9365921
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Effect of different hapten-carrier conjugation ratios and molecular orientations on antibody affinity against a peptide antigen.
    Pedersen MK; Sorensen NS; Heegaard PM; Beyer NH; Bruun L
    J Immunol Methods; 2006 Apr; 311(1-2):198-206. PubMed ID: 16574142
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Platelet integrin alpha2 I-domain specific antibodies produced via domain specific DNA vaccination combined with variable gene phage display.
    Hughes DL; Stafford P; Hamaia SW; Harmer lJ; Schoolmeester A; Deckmyn H; Farndale RW; Ouwehand WH; Watkins NA
    Thromb Haemost; 2005 Dec; 94(6):1318-26. PubMed ID: 16411412
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Anti-idiotypic antibody mimics proteolytic function of parent antigen.
    Ponomarenko NA; Pillet D; Paon M; Vorobiev II; Smirnov IV; Adenier H; Avalle B; Kolesnikov AV; Kozyr AV; Thomas D; Gabibov AG; Friboulet A
    Biochemistry; 2007 Dec; 46(50):14598-609. PubMed ID: 18020454
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Design and synthesis of an alpha,alpha-difluorophosphinate hapten for antibody-catalyzed hydrolysis of organophosphorus nerve agents.
    Vayron P; Renard PY; Valleix A; Mioskowski C
    Chemistry; 2000 Mar; 6(6):1050-63. PubMed ID: 10785826
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The generation of antibody combining sites containing catalytic residues.
    Shokat KM; Schultz PG
    Ciba Found Symp; 1991; 159():118-28; discussion 128-34. PubMed ID: 1959444
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.